"N Engl J Med"[journal] 检索结果

701. Thirty Years of Hydroxyurea for Sickle Cell Anemia - Scientific Progress, Global Health Gaps.

作者: Enrico Costa.;Russell Ware.;Leon Tshilolo.;Lucio Luzzatto.
来源: N Engl J Med. 2025年393卷16期1556-1559页

702. Fetal Personhood and Reproductive Criminalization - Implications for Patients, Clinicians, and Public Health.

作者: Taylor Riley.;Asha Hassan.
来源: N Engl J Med. 2025年393卷16期1559-1561页

703. Involving Palliative Care to Improve Outcomes in Sickle Cell Disease.

作者: Eberechi Nwogu-Onyemkpa.;Griffin Collins.;Mgbechi Erondu.;Erica C Kaye.
来源: N Engl J Med. 2025年393卷16期1553-1556页

704. Living in the Present Tense.

作者: James A Feinstein.
来源: N Engl J Med. 2025年393卷16期1561-1563页

705. Thoracic Ectopia Cordis.

作者: Zeljko Duric.;Hrvoje Gasparovic.
来源: N Engl J Med. 2025年393卷16期e26页

706. Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.

作者: Pasi A Jänne.;David Planchard.;Kunihiko Kobayashi.;James Chih-Hsin Yang.;Ying Liu.;Natalia Valdiviezo.;Tae Min Kim.;Liyan Jiang.;Hiroshi Kagamu.;Noriko Yanagitani.;Jialei Wang.;Bivas Biswas.;Artem Poltoratskiy.;Yeni Neron.;Carlos Rojas.;Leona Koubkova.;Carles Escriu.;Doreen A Ezeife.;Helen Mann.;Elena Armenteros-Monterroso.;Yuri Rukazenkov.;Chee Khoon Lee.; .
来源: N Engl J Med. 2026年394卷1期27-38页

The primary analysis of this trial showed that first-line treatment with osimertinib plus chemotherapy with a platinum-based agent and pemetrexed led to significantly longer progression-free survival than osimertinib monotherapy among patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer (NSCLC). Results from the planned final analysis of overall survival are needed.

707. Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.

作者: Xiuning Le.;Tae Min Kim.;Herbert H Loong.;Arsela Prelaj.;Boon Cher Goh.;Lin Li.;Yong Fang.;Shun Lu.;Xiaorong Dong.;Lin Wu.;Yuki Shinno.;Gennaro Daniele.;Tsung-Ying Yang.;Hye Ryun Kim.;Gerrina Ruiter.;Jun Zhao.;Silvia Novello.;Liyun Miao.;Pasi A Jänne.;Koichi Goto.;Dominik Rüttinger.;Tine Descamps.;Jan Christoph Brase.;Weichao Bao.;Rui Li.;Nicoletta Brega.;Paolo Grassi.;Nicolas Girard.;Daniel Shao-Weng Tan.; .
来源: N Engl J Med. 2025年393卷18期1819-1832页

HER2 gene mutations occur in 2 to 4% of patients with non-small-cell lung cancer (NSCLC). Sevabertinib is an oral, reversible tyrosine kinase inhibitor that has shown anti-HER2 activity in preclinical models.

708. Is a Long-Simmering Crisis Boiling Over? U.S. Primary Care Today.

作者: Lisa Rosenbaum.
来源: N Engl J Med. 2025年393卷15期1537-1541页

709. More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism. Reply.

作者: Adina F Turcu.;Mason W Freeman.;Morris J Brown.
来源: N Engl J Med. 2025年393卷15期1550-1552页

710. More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism.

作者: Tobias Carling.;Ute I Scholl.
来源: N Engl J Med. 2025年393卷15期1550页

711. Competency-Based Medical Education at the Front Lines of Patient Care. Reply.

作者: Dawn Cooper.;Eric S Holmboe.
来源: N Engl J Med. 2025年393卷15期1549-1550页

712. Competency-Based Medical Education at the Front Lines of Patient Care.

作者: Kévin Yauy.;Camille Roubille.
来源: N Engl J Med. 2025年393卷15期1548-1549页

713. Competency-Based Medical Education at the Front Lines of Patient Care.

作者: George W Meyer.
来源: N Engl J Med. 2025年393卷15期1548页

714. Competency-Based Medical Education at the Front Lines of Patient Care.

作者: Alexander A Iyer.;Nicole M Dubosh.;Richard M Schwartzstein.
来源: N Engl J Med. 2025年393卷15期1548页

715. BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.

作者: Laura Bucci.;Sebastian Böltz.;Melanie Hagen.;Carlo Tur.;Danae-Mona Nöthling.;Tobias Rothe.;Andreas Wirsching.;Janina Auth.;Jochen Wacker.;Markus Eckstein.;Stefano Alivernini.;Aline Bozec.;Christina Bergmann.;Maria-Antonietta D'Agostino.;Luis Munoz.;Jürgen Rech.;Lars Kihm.;Maria Gabriella Raimondo.;Georg Schett.;Ricardo Grieshaber-Bouyer.
来源: N Engl J Med. 2025年393卷15期1544-1547页

716. Sentinel Lymphadenectomy for Early-Stage Cervical Cancer - the New Standard?

作者: Kristin Bixel.
来源: N Engl J Med. 2025年393卷15期1534-1536页

717. Case 29-2025: A 43-Year-Old Woman with Depression, Suicidal Ideation, and Fever.

作者: Michael S Abers.;Robert J Lawson.;Sandra B Nelson.;Melanie C Kwan.
来源: N Engl J Med. 2025年393卷15期1522-1531页

718. Stercoral Colitis.

作者: Aleksandra Bajer.;Erica Levine.
来源: N Engl J Med. 2025年393卷15期e23页

719. Hair Loss in Women.

作者: Elise A Olsen.
来源: N Engl J Med. 2025年393卷15期1509-1520页

720. Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality.

作者: Fadima Cheick Haidara.;Laura Adubra.;Mahamadou Abdou.;Dagmar Alber.;Ulla Ashorn.;Yin Bun Cheung.;Elaine Cloutman-Green.;Mamadou Diallo.;Camilla Ducker.;Yue-Mei Fan.;Gwydion Gruffudd.;Lotta Hallamaa.;Tiia Haapaniemi.;Rikhard Ihamuotila.;Jane Juma.;Nigel Klein.;Juho Luoma.;Owen Martell.;Akshaya Murugesan.;Collins Okello.;Oumar Samaké.;Cheick Amadou Tidiane Traore.;Taru Vehmasto.;Kaisa Ylikruuvi.;Samba Sow.;Per Ashorn.
来源: N Engl J Med. 2025年393卷15期1498-1508页

Mass administration of azithromycin to children 1 to 59 months of age has been shown to reduce mortality among infants and children in this age group in some areas of sub-Saharan Africa. The largest effects have appeared to be among infants younger than 12 months of age, within 3 months after treatment; this observation motivated the design of the current trial.

结果排序

文献格式

出版时间

出版类型

出版语言